3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
474
Carcinoma, Non-Small-Cell Lung
450
Breast Neoplasms
331
Neoplasm Metastasis
244
Colorectal Neoplasms
214
Melanoma
213
Leukemia, Myeloid, Acute
190
Multiple Myeloma
180
Recurrence
169
Ovarian Neoplasms
169
Prostatic Neoplasms
163
Lymphoma, Non-Hodgkin
149
Lung Neoplasms
134
Pancreatic Neoplasms
125
Lymphoma
124
Carcinoma, Renal Cell
112
Squamous Cell Carcinoma of Head and Neck
111
Leukemia, Lymphocytic, Chronic, B-Cell
111
Stomach Neoplasms
92
Carcinoma, Hepatocellular
89
Lymphoma, Large B-Cell, Diffuse
88
Leukemia
88
Triple Negative Breast Neoplasms
87
Lymphoma, Follicular
82
Head and Neck Neoplasms
79
Glioblastoma
76
Myelodysplastic Syndromes
70
Urinary Bladder Neoplasms
68
Small Cell Lung Carcinoma
65
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Interventions
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
INDUSTRY
×
Physician Education
×
Clear all
NCT02287025
2017-10-19
SMART
Bayer
Phase 4
Terminated
23 enrolled
6 charts